Israel is launching a new national initiative to improve breast cancer care, following Yuvital’s selection as the winning startup of the Breast Cancer Innovation Challenge 2025. The program brings together healthcare providers, technology innovators, and ecosystem partners to address gaps in diagnosis, care coordination, and patient support across the breast cancer journey.

Yuvital’s win in the challenge recognizes its ability to translate real clinical needs into scalable, patient-centered solutions. The initiative reflects a growing understanding that improving cancer outcomes requires more than medical excellence alone. It demands integrated approaches that combine clinical insight, data, technology, and system-level collaboration.

The Breast Cancer Innovation Challenge 2025 was led by Roche Israel, in collaboration with Sheba’s Breast Cancer Institute, ARC Innovation, and the Israel National Digital Health Program, to accelerate impactful solutions in breast cancer care.